Amin, M., Desai, M., Trinkaus, K., Brown, A., Wang-Gillam, A., Tan, B., . . . Lockhart, A. C. (2019). Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer. J Gastrointest Oncol.
Style de citation ChicagoAmin, Manik, et al. "Phase II Trial of Levocetirizine With Capecitabine and Bevacizumab to Overcome the Resistance of Antiangiogenic Therapies in Refractory Metastatic Colorectal Cancer." J Gastrointest Oncol 2019.
Style de citation MLAAmin, Manik, et al. "Phase II Trial of Levocetirizine With Capecitabine and Bevacizumab to Overcome the Resistance of Antiangiogenic Therapies in Refractory Metastatic Colorectal Cancer." J Gastrointest Oncol 2019.